Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian… Read more
Luyan Pharma Co Ltd (002788) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥118.98 Million) by net assets (CN¥3.26 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Luyan Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Luyan Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Luyan Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Luyan Pharma Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIPEF SA (POST SPLIT)
F:BZ3
|
N/A |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728
|
0.025x |
|
Investis Holding SA
SW:IREN
|
0.016x |
|
DOM DEVELOPMENT SE.A.ZY 1
F:6WV
|
N/A |
|
Chongqing Shunbo Aluminum Co Ltd
SHE:002996
|
-0.026x |
|
The Hongkong and Shanghai Hotels Limited
F:HSG
|
0.005x |
|
Vishay Precision Group Inc
NYSE:VPG
|
-0.004x |
|
Internacional de Cerámica S.A.B. de C.V
MX:CERAMICB
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Luyan Pharma Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Luyan Pharma Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.19 Billion | CN¥577.48 Million | 0.181x | -58.86% |
| 2023-12-31 | CN¥2.98 Billion | CN¥1.31 Billion | 0.440x | +428.54% |
| 2022-12-31 | CN¥2.79 Billion | CN¥232.19 Million | 0.083x | +157.26% |
| 2021-12-31 | CN¥2.56 Billion | CN¥-372.02 Million | -0.145x | -552.79% |
| 2020-12-31 | CN¥2.41 Billion | CN¥77.22 Million | 0.032x | +109.63% |
| 2019-12-31 | CN¥1.89 Billion | CN¥-629.14 Million | -0.333x | -534.66% |
| 2018-12-31 | CN¥1.65 Billion | CN¥126.77 Million | 0.077x | +126.85% |
| 2017-12-31 | CN¥1.57 Billion | CN¥-447.16 Million | -0.285x | -207.31% |
| 2016-12-31 | CN¥1.38 Billion | CN¥-128.03 Million | -0.093x | -31699.60% |
| 2015-12-31 | CN¥746.00 Million | CN¥219.31K | 0.000x | -99.89% |
| 2014-12-31 | CN¥649.30 Million | CN¥177.89 Million | 0.274x | +299.88% |
| 2013-12-31 | CN¥557.87 Million | CN¥-76.47 Million | -0.137x | -86.46% |
| 2012-12-31 | CN¥448.15 Million | CN¥-32.94 Million | -0.074x | -193.16% |
| 2011-12-31 | CN¥354.91 Million | CN¥28.01 Million | 0.079x | -- |